Global Medical Polymers Market is valued at USD 18.37 Billion in 2021 and is expected to reach USD 34.68 Billion by 2028 with a CAGR of 9.5% over the forecast period.
Global Medical Polymers Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2028; Rising used of surgical instruments, increasing use of mask, gloves etc., and rising cases of Covid-19 are some of the major factors expected to accelerate demand for the Medical Polymers market.
Medical polymers is the term used for biodegradable plastic, elastomers such as thermoplastic elastomers and natural, and polymers such as fibers and resins which are employed in different forms in healthcare and medical applications. Medical polymers include ceramics, glass, and metals have been employed as medical supports, devices, and implants. However, polymers are a more suitable for medical applications owing to minimum cost, superior biocompatibility and less weight. Medical polymers are mostly used in equipment and devices such as implants for cranial injuries, joint and hip replacement, spinal implants and many others. Additionally, the strict regulations regarding the release of new products along with fluctuating prices of raw materials may impede the growth of the market to some extent.
Covid-19 has shown a positive impact on the growth of the medical polymers market. The demand is increased due to the rising polymer demand to the increased demand for disposable masks, face shields, and swabs. The polymer latter is used to collect fluid samples for testing Covid-19. And also continuous rise in the demand for medical packaging products for Covid-19 has also influenced the market positively.
The medical polymers market is segmented on the basis of polymer material, application and region & country level. On the basis of polymer material, the medical polymers market is classified into medical grade polypropylene, medical grade polyvinyl chloride, medical-grade polyethylene, medical-grade polyesters, polyvinyl pyrrolidone (PVP), PEEK, polycarbonate and others. On the basis application, the medical polymers market is classified into packaging, implants, medical wear, and medical devices. Packaging polymer is sub-segmented into the injections, medical bags, medical tubes, pharmaceutical blisters and trays, microplates, vials, blister packs and others. Implants are sub-segmented into the breast implants, orthopedic implants, spinal implants and others. Medical wear is sub-segmented into the gloves, face shields, masks & gowns and others. Medical devices are sub-segmented into pacemakers, dental & orthodontic devices, catheters, contact lenses and others.
The regions covered in this medical polymers market report are Asia-Pacific, North America, Europe, and the Rest of the World. Based on a country level, the market of medical polymers is subdivided into the U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, Southeast Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.
Some of the key players for medical polymers are
On November 17th, 2021; Evonik offered a broader range of RESOMER Print Powder polymers to enable the 3D printing of personalized implantable medical devices. The new powders are available globally for 3D printing through selective laser sintering (SLS).
On July 1st, 2021; Eastman Chemical Co. announced the launch of a new family of medical-grade polymers at the MedTec Europe trade show in Stuttgart, Germany. Medical grades of Eastman Tritan copolyester are clear polymers that deliver a balance of design, molding and end-product properties for medical devices.
On March 25th, 2021; BASF announced it is going to increase innovation capabilities for its superabsorbent polymer business by building a state-of-the-art Superabsorbent Excellence Center at its Verbund site in Antwerp, Belgium.
The vast applications of medical polymers in the growing use of surgical instruments in hospitals are driving the demand for medical polymers. For example; according to the world journal of surgery in India, a total of 3646 surgeries were estimated annually. According to the WHO, it’s estimated that 234·2 million major surgical procedures are undertaken every year worldwide. According to the healthcare in India 2020, India has a total of 43,486 private hospitals, Total private infrastructure accounts for nearly 62% of India’s entire health infrastructure. According to the healthcare industry in India, the total hospital industry in India accounts for 80% of the total healthcare market. According to the American Hospital Association (AHA) in 2021, there are a total of 6,146 hospitals in the United States majorly used of medical polymer instruments in the hospitals. From test equipment similar to vials and beakers to surgical instruments, catheters, and implants, plastics are used more and more for their high performance, lightweight, and lower costs. Plastics can be used as a material for handles of surgical devices, due to their high impact resistance and thermal stability. Further, this material desires low maintenance and less sterilization. As well as, plastic medical devices steadily replacing other materials such as glass, ceramics, and metals, wherever applicable. So, a medical polymer is highly used in surgical instruments.
Increasing use of mask, gloves coupled with the rising cases of Covid-19 is also supplementing the market growth. During the pandemic, demand for personal protective equipment (PPE), including masks, has soared to unprecedented levels. For example; according to the UNICEF; in the United Nations has forecasted the demand for surgical masks alone to be in the region of 2.4 billion in 2020 as well as UNICEF has supply 385 million surgical masks and 23.3 million N95 respirators, and reached 134 countries. Respirators are masks used to decrease exposure to hazardous airborne particles, containing dust particles and infectious agents, as well as gases and vapors. In the Covid-19 pandemic, respirators are reserved for use by health workers performing aerosol-generating procedures or providing direct care to Covid-19 patients. Furthermore, growing demand for biodegradable polymers is a trend driving growth of the global medical polymers market over the forecast period.
However, high price of raw material may hamper growth of the medical polymers market during the forecast period. In addition, strict rules and regulation by government bodies for example U.S. Food and Drug Association (FDA) and European Union (EU), is one more factor hampering growth of the target market. Despite that, increasing investment by government in research and development activities may offer an opportunity for the further growth of the market.
Geographically, North America is expected to dominate the global medical polymers market. The growth in the geriatric population is augmenting healthcare needs, thereby fueling the market growth of the medical polymers. Growing aging population is increasing the prevalence of chronic disease which is escalating the demand for medical products. According to the U.S. research centers, 22% of the U.S. population is age 60 and older as well as according to the WHO, between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. Additionally, according to the NIH (national cancer institute) Cancer has a major impact on society in the United States and across the world. Recently, in 2020, an estimated 1,806,590 new cases of cancer will be diagnosed in the United States and 606,520 people will die from the disease. As of January 2019, there were a predictable 16.9 million cancer survivors in the United States.
The factors driving the growth of APAC is fastest growing medical polymers market are the increasing availability of medical polymer in this region and huge growth potential driven by the increasing demand for a better healthcare system. APAC consists of some vast and fast growing economies, such as China, India, Indonesia, Malaysia, Vietnam, and Thailand. Across these economies, local governments are restructuring regulations in fields such as IT integration, advanced materials, and others in the healthcare industry to increase the efficiency and efficacy of medical devices and related healthcare services.
Middle East and Africa
|Historical data||2015 - 2020|
|Forecast Period||2021 - 2028|
|Market Size in 2021:||USD 18.37 Billion|
|Base year considered||2020|
|Forecast Period CAGR %:||
|Market Size Expected in 2028:||USD 34.68 Billion|
|Tables, Charts & Figures:||175|
|Medical Polymer Manufacturers||BASF SE, Bayer Material Science AG, Celanese Corporation, DSM N.V., DuPont, Eastman Chemical, Evonik Industries AG, Exxon Mobil Corporation, Dow, Inc., Huizhou Foryou Medical Device Co. Ltd., Kraton Performance Polymers Inc., Tianjin Plastics Research Institute Co. Ltd., Formosa Plastics Corporation, Shanghai New Shanghua Polymer Material Co. Ltd, Sinopec Beijing Yanshan Company and others.|
|Segments Covered||By Polymer Material, By Application|
|Regional Analysis||North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa|
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us firstname.lastname@example.orgJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
Kemp House, 152 - 160 City Road, London EC1V 2NX
© Copyright 2022-23 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®